Sfoglia per AUTORE
GRäFE S
Collezione AOU Alessandria

  

Items : 15

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. in American journal of hematology / Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23.
2025
AOU Alessandria
AOU Città della Salute di Torino

D?browska-Iwanicka A; Brunetti SC; Drozd-Soko?owska J; van den Ven L; Fianchi L; Limongelli A; Sciumè M; Leotta D; Bavastro M; Musto P; Delia M; Wolf D; Anastasopoulou AN; Mayer J; Víšek B; Varricchio G; Arellano E; Córdoba R; Cerchione C; Prin R; Cvetanoski M; Mitrovi? M; Aiello TF; Glenthøj A; Gräfe SK; Schönlein M; Hersby DS; Adži?-Vuki?evi? T; Coppola N; et alii...

Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. in EClinicalMedicine / EClinicalMedicine. 2024 Mar 18;71:102553. doi: 10.1016/j.eclinm.2024.102553. eCollection 2024 May.
2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pagano L; Cornely OA; Koehler P; Rahimli L; Hanáková M; Rá?il Z; Bonanni M; Nygaard M; García-Bordallo D; Çolak GM; Mayer J; Sacchi MV; Krekeler C; Infante MS; Jindra P; Zompi S; Mitrovi? M; Miškovi? B; Mladenovi? M; Coppola N; Otaševi? V; Prattes J; Gavriilaki E; Tragiannidis A; Groh A; Serrano L; Drgo?a ?; Serris A; Gonzaga Y; et alii...

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. in Infection / Infection. 2024 Jun;52(3):1125-1141. doi: 10.1007/s15010-023-02169-7. Epub 2024 Feb 22.
2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rasch S; Rahimli L; Cornely OA; Pagano L; Dibos M; Bavastro M; Prattes J; Egger M; Limongelli A; Cvetanoski M; García-Sanz R; Arellano E; Zambrotta GPM; Aiello TF; Wolf D; Núñez-Martín-Buitrago L; Nunes Rodrigues R; Hersby DS; Hanakova M; Víšek B; Cabirta A; Nordlander A; ?er?an M; Gräfe SK; Mladenovi? M; Miškovi? B; Ilhan O; Ammatuna E; Çolak GM; et alii...

2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Dibos M; Cvetanoski M; Bavastro M; Limongelli A; Egger M; Prattes J; García-Sanz R; Aiello TF; Arellano E; Wolf D; Núñez-Martín-Buitrago L; Zambrotta GPM; Hersby DS; Nunes Rodrigues R; Nordlander A; Víšek B; Cabirta A; Gräfe SK; Ammatuna E; Hanakova M; ?er?an M; Çolak GM; Ilhan O; Bara? A; Mladenovi? M; Miškovi? B; Kohn M; Emarah Z; Stojanoski Z; et alii...

The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey. in Leukemia & lymphoma / Leuk Lymphoma. 2024 Feb;65(2):199-208. doi: 10.1080/10428194.2023.2280886. Epub 2024 Jan 24.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Gräfe S; Cordoba R; Hersby DS; Ammatuna E; Rá?il Z; Nordlander A; Miškovi? B; Mladenovi? M; Arellano E; Adži?-Vuki?evi? T; Al-Khabori M; Blennow O; Collins GP; Calbacho M; De Jonge N; Demirkan F; Espigado I; Kulasekararaj A; Labrador J; Ormazabal-Vélez I; Bonnani M; Rinaldi I; Glenthøj A; López-García A; Maertens J; Meers S; Méndez GA; Passamonti F; Van Doesum J; et alii...

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2023 Oct;62(4):106952. doi: 10.1016/j.ijantimicag.2023.106952. Epub 2023 Au
2023
AOU Alessandria
AOU San Luigi di Orbassano

Mladenovi? M; Bavastro M; Limongelli A; Rahimli L; Miškovi? B; Marchetti M; Nordlander A; Blennow O; Cordoba R; Wolf D; Çolak GM; Arellano E; Hersby DS; Gräfe S; Kohn M; Calbacho M; Besson C; Dargenio M; Del Principe MI; Glenthøj A; Fouquet G; Hernández-Rivas JÁ; Labrador J; Merelli M; Pantic N; Mitrovic M; Schönlein M; Gavriilaki E; Tragiannidis A; et alii...

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey. in Blood advances / Blood Adv. 2023 Jun 13;7(11):2645-2655. doi: 10.1182/bloodadvances.2022009578.
2023
AOU Alessandria

van Doesum JA; Salmanton-García J; Marchesi F; Di Blasi R; Falces-Romero I; Cabirta A; Farina F; Besson C; Weinbergerová B; Van Praet J; Schönlein M; López-García A; Lamure S; Guidetti A; De Ramón-Sánchez C; Batini? J; Gavriilaki E; Tragiannidis A; Tisi MC; Plantefeve G; Petzer V; Ormazabal-Vélez I; Marques de Almeida J; Marchetti M; Maertens J; Machado M; Kulasekararaj A; Hernández-Rivas JÁ; Gomes da Silva M; et alii...

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA). in Haematologica / Haematologica. 2023 Jan 1;108(1):22-33. doi: 10.3324/haematol.2022.280847.
2023
AOU Alessandria
AOU Città della Salute di Torino

Hoenigl M; Ammatuna E; Busca A; Corradini P; Rahimli L; Gräfe S; Khostelidi S; Martín-González JA; García-Poutón N; Sacchi MV; Rodrigues RN; Booth S; Sciumè M; Zambrotta G; Hanakova M; El-Ashwah S; Cordoba R; Calbacho M; Bahr NC; Cattaneo C; De Ramón-Sánchez C; Fazzi R; Glenthøj A; Sramek J; Kulasekararaj A; Jindra P; Navrátil M; Piedimonte M; Petzer V; et alii...

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2023 Dec;137:98-110. doi: 10.1016/j.ijid.2023.10.013. Epub 2023 Oct 18.
2023
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pagano L; Cordoba R; Cornely OA; Hanakova M; Rahimli L; Sacchi MV; Nunes Rodrigues R; Hersby DS; Ammatuna E; Cabirta A; Zambrotta GPM; Nordlander A; Arellano E; Mladenovi? M; Aiello TF; Núñez-Martín-Buitrago L; Gräfe SK; Miškovi? B; Emarah Z; García-Sanz R; Çolak GM; Wolf D; Limongelli A; Ilhan O; Calbacho M; Bara? A; Bavastro M; Merelli M; Biernat MM; et alii...

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. in EClinicalMedicine / EClinicalMedicine. 2023 Apr;58:101939. doi: 10.1016/j.eclinm.2023.101939. Epub 2023 Apr 6.
2023
AOU Alessandria
AOU San Luigi di Orbassano

Blennow O; Nordlander A; Cabirta A; Cattaneo C; Merelli M; Hernández-Rivas JÁ; Aujayeb A; Jiménez M; Nucci M; Papa MV; Plantefeve G; Del Principe MI; Duléry R; Anastasopoulou AN; De Jonge N; Tascini C; Fernández N; Batini? J; Ormazabal-Vélez I; Cuccaro A; Lahmer T; Valkovi? T; Biernat MM; Besson C; Finizio O; Marques de Almeida J; Marchetti M; Weinbergerová B; Delia M; et alii...

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry. in Therapeutic advances in hematology / Ther Adv Hematol. 2023 Mar 11;14:20406207231154706. doi: 10.1177/20406207231154706. eCollection 2023
2023
AOU Alessandria
AOU San Luigi di Orbassano

Arellano E; Wolf D; Gräfe SK; Nordlander A; Cabirta A; Collins GP; Demirkan F; Jiménez M; Ledoux MP; Maertens J; Mitra ME; Magliano G; Samarkos M; Schönlein M; Cernan M; Blennow O; ?olovi? N; Duarte R; Bergantim R; Jaksic O; Meers S; Prezioso L; Bonuomo V; Buquicchio C; Espigado I; Petzer V; Glenthøj A; Žák P; Bilgin YM; et alii...

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry. in Frontiers in immunology / Front Immunol. 2023 Feb 24;14:1125030. doi: 10.3389/fimmu.2023.1125030. eCollection 2023.
2023
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cornely OA; Dargenio M; Rahimli L; Gavriilaki E; Groh A; Itri F; López-García A; Petzer V; Tragiannidis A; Van Praet J; Berg Venemyr C; Gräfe S; Cabirta A; Hanakova M; Dragonetti G; Karlsson LK; Zambrotta GPM; Nordlander A; Zompi S; Antoniadou A; Tsirigotis P; Ammatuna E; Ilhan O; Falces-Romero I; Magliano G; Marchetti M; De Kort E; Ribera-Santa Susana JM; Kulasekararaj A; et alii...

Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey. in Cancers / Cancers (Basel). 2022 Nov 10;14(22):5530. doi: 10.3390/cancers14225530.
2022
AOU Alessandria
AOU San Luigi di Orbassano

Berg Venemyr C; Nordlander A; Çolak GM; Sacchi MV; Mladenovi? M; Gräfe S; Sciumè M; Rahimli L; Aujayeb A; Bilgin YM; Cuccaro A; Drgo?a ?; Hoenigl M; Pinczés LI; Maertens J; Meers S; Ormazabal-Vélez I; Samarkos M; Szotkowski T; Verga L; Al-Khabori M; Batini? J; Bergantim R; Del Principe MI; Buquicchio C; Erben N; Garcia-Vidal C; Jiménez M; Magliano G; et alii...

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report. in HemaSphere / Hemasphere. 2022 Oct 25;6(11):e789. doi: 10.1097/HS9.0000000000000789. eCollection 2022 Nov.
2022
AOU Alessandria
AOU Città della Salute di Torino

Berg Venemyr C; Cornely OA; Ammatuna E; Gräfe S; Wolf D; Arellano E; Çolak GM; Koehler P; Rahimli L; Busca A; Corradini P; Hoenigl M; Prezioso L; Marchetti M; Meers S; Buquicchio C; Pinczés LI; de Jonge N; Soto-Silva A; Sili U; Serrano L; Aujayeb A; Espigado I; Dargenio M; Farina F; Schönlein M; Chanut M; Petzer V; van Doesum J; et alii...

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. in Blood / Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257.
2022
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Corradini P; Pagliuca A; Passamonti F; Bonanni M; Labrador J; Rahimli L; Verga L; Cattaneo C; Adži?-Vuki?evi? T; Machado M; Gräfe S; Sili U; Hanáková M; Nucci M; Mladenovi? M; Liévin R; Prezioso L; Rá?il Z; Guidetti A; Demirkan F; Sacchi MV; Fernández N; Zambrotta G; Fouquet G; Marchetti M; Batini? J; Aujayeb A; de Jonge N; de Ramón C; et alii...